Jaar: 2024

Userful onthult zeven baanbrekende innovaties voor haar Infinity Platform, waarmee haar leiderschap in bedrijfs-AV over IP wordt versterkt

BARCELONA, Spanje–(BUSINESS WIRE)– Userful™, een vooraanstaande provider van IT-oplossingen voor belangrijke bedrijfsactiviteiten, heeft zeven verbeteringen aangekondigd, die een primeur zijn voor de sector, voor haar...

Ubiquiti Inc. Introduces UniFi 7, A Massively Scalable Wi-Fi 7 Solution That Revolutionizes Wireless Connectivity

NEW YORK–(BUSINESS WIRE)– Ubiquiti Inc. (NYSE: UI) (“Ubiquiti”) today announced UniFi 7 — a massively scalable Wi-Fi 7 solution capable of delivering wired-like user experiences....

TRG onthult nieuwe mondiale positionering met robuuste nieuwe merknaam en website

Vooraanstaande internationale provider van beheerde oplossingen start 2024 met een nieuwe, krachtige positionering in lijn met haar uitgebreide mondiale voetafdruk na een explosieve groei van...

Home Connectivity Alliance Announces HCA Energy Management Interface Specification 1.0 at CES 2024

HCA is comprised of 17 global brands, including AEG, American Standard, Arçelik, Beko, Electrolux, Frigidaire, GE Appliances, Grundig, Haier, HSB, Leader, LG, Midea, Resideo, Samsung,...

VeriSilicon Unveils the New VC9800 IP for Next Generation Data Centers

Delivering exceptional throughput, AI-powered encoding, and superb image enhancement for data centers LAS VEGAS–(BUSINESS WIRE)– VeriSilicon (688521.SH) today unveiled its latest VC9800 series Video Processor...

Validant Group of Companies Unite as ELIQUENT Life Sciences

Strategic Repositioning Creates Unprecedented Assembly of Regulatory Expertise & Global Capabilities WASHINGTON–(BUSINESS WIRE)– The Validant Group of companies today announced a strategic repositioning that unites...

Morgan Stanley Expansion Capital Leads $34M Series C Investment in Vortexa

LONDON–(BUSINESS WIRE)– Vortexa, the leading real-time global analytics platform for energy and freight markets, is excited to announce the successful completion of its $34 million...

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

BEIJING & BOSTON–(BUSINESS WIRE)– Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today...

ExaGrid’s FY 2023 Results—A Record-Breaking Year for Company

ExaGrid reports a record bookings and revenue quarter in Q4 2023, and 12 consecutive quarters of positive P&L, EBITDA, and free cash flow MARLBOROUGH, Mass.–(BUSINESS...

D3 Security is a proud participant in the Microsoft Security Copilot Partner Private Preview

VANCOUVER, British Columbia–(BUSINESS WIRE)– D3 Security today announced its participation in the Microsoft Security Copilot Partner Private Preview. D3 Security was selected based on their...

Debiopharm Extends SunRock Biopharma Partnership for Antibody Drug Conjugates Targeting HER3 in EGFR Mutated Cancers

LAUSANNE, Switzerland & SANTIAGO DE COMPOSTELA, Spain–(BUSINESS WIRE)– Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious...

TRG Unveils New Global Positioning with Bold New Brand and Website

Leading global managed solutions provider starts 2024 with a new powerful positioning to match its expanded global footprint after years of explosive growth CLEVELAND–(BUSINESS WIRE)–...

Lokaal denken is essentieel voor leveranciers van clouddiensten in de EU

Europese providers zoeken een evenwicht tussen gegevenssoevereiniteit en cloudschaalbaarheid in een omgeving waar de regelgeving toeneemt, aldus het ISG Provider Lens™-rapport LONDEN–(BUSINESS WIRE)– Europese dienstverleners...

Thinking Local Is Key for EU’s Cloud Service Providers

European providers are balancing data sovereignty with cloud scalability in an environment marked by increased regulations, ISG Provider Lens™ report says LONDON–(BUSINESS WIRE)– European service...

Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock

Novel biomarker-guided Phase 3 registration trial in septic shock with an enrichment strategy-based patient selection. Historic paradigm shift in Primary endpoint: from all causes of...